NZM2:ETR
Novozymes A/S
€58.00
0.00%
(0.00) 1D
Oct 9, 5:35:30 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM2...
Open
€57.64
High
€58.10
Low
€57.64
Mkt. cap
180.41B
Avg. vol.
120.00
Volume
5.00
52-wk high
€61.96
52-wk low
€46.74
No. of employees
11K
Open
€57.64
High
€58.10
Low
€57.64
Mkt. cap
180.41B
Avg. vol.
120.00
Volume
5.00
52-wk high
€61.96
52-wk low
€46.74
No. of employees
11K
News stories
From web sources and news partners
Insider Monkey
·
30 minutes ago
Dell (DELL) Has Outpaced the S&P 500 by a Wide Stretch. Will the AI-Fueled Run Continue?
The Motley Fool
·
2 hours ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
MarketWatch
·
7 hours ago
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S